Knobloch, Jürgen http://orcid.org/0000-0001-6868-0055
Panek, Susanne
Yanik, Sarah Derya
Jamal Jameel, Kaschin
Bendella, Zeynep
Jungck, David
Bürger, Paul
Bülthoff, Eike
Struck, Birte
Giannakis, Nikolaos
Rupp, Jan
Kronsbein, Juliane
Peters, Marcus
Koch, Andrea
Funding for this research was provided by:
FoRUM Program of the Ruhr University Bochum (F716R-2011)
Article History
Received: 5 June 2018
Revised: 4 March 2019
Accepted: 13 March 2019
First Online: 30 March 2019
Compliance with ethical standards
: The study was approved by the Ethics Committees of the University of Cologne, Germany (02-004) and of the University of Bochum, Germany (4257-12, 4772-13) and all patients gave written consent.
: Dr. Jungck reports payment for lectures from Novartis as well as travel support from Actelion, Boehringer Ingelheim, Teva, Sanofi, and Roche; Dr. Knobloch reports personal fees from AstraZeneca, personal fees from Teva, personal fees from Novartis, personal fees from Actelion Pharmaceuticals, and personal fees from Boehringer Ingelheim, outside the submitted work; Dr. Kronsbein reports personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, and personal fees from Novartis, outside the submitted work; Dr. Peters reports personal fees from Biotest AG, personal fees from Protectimmun GmbH, grants from Dr. Georg E. und Marianne Kosing-Stiftung, grants from Georgius Agricola Stiftung Ruhr, and grants from Phenox GmbH, outside the submitted work; Dr. Bendella, Mr. Bülthoff, Dr. Bürger, Dr. Giannakis, Mrs. Jamal Jameel, Dr. Koch, Dr. Panek, Dr. Rupp, Mrs. Struck, and Dr. Yanik have nothing to disclose.